1)Wolf JS Jr, Bennett CJ, Dmochowski RR, et al:Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol 179:1379-1390, 2008
2)Grabe M, Bartoletti R, Bjerklund-Johansen TE, et al:EAU guidelines on prostate cancer 2013 updated. http://www.uroweb.org/gls/pdf/09_Prostate_Cancer_LR.pdf
3)松本哲朗,村谷哲郎,山田陽司,他:泌尿器科領域における周術期感染予防ガイドライン.日泌会誌97:18-20,2006
4)Aron M, Rajeev TP, Gupta NP, et al:Antibiotic prophylaxis for transrectal needle biopsy of the prostate:a randomized controlled study. BJU Int 85:682-685, 2000
5)Griffith BC, Morey AF, Ali-Khan MM, et al:Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk. J Urol 168:1021-1023, 2002
6)Williamson DA, Barrett LK, Rogers BA, et al:Infectious complications following transrectal ultrasound-guided prostate biopsy:new challenges in the era of multidrug-resistant Escherichia coli. Clin Infect Dis 57:267-274, 2013
7)Minamida S, Satoh T, Tabat K, et al:Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy. Urology 78:1235-1239, 2011
8)Oosterlinck W, Defoort R and Renders G:The concentration of sulphamethoxazole and trimethoprim in human prostate gland. Br J Urol 47:301-304, 1975
9)Mosharafa AA, Torky MH, El Said WM, et al:Rising incidence of acute prostatitis following prostate biopsy:fluoroquinolone resistance and exposure is a significant risk factor. Urology 73:511-514, 2011
10)Feliciano J, Teper E, Ferrandino M, et al:The incidence of fluoroquinolone resistant infections after prostate biopsy—are fluoroquinolones still effective prophylaxis? J Urol 179:952-955, 2008
11)Schaeffer AJ, Montorsi F and Scattoni:Comparison of a 3-day with a 1-day regimen of an extended-release formulation of ciprofloxacin as antimicrobial prophylaxis for patients undergoing transrectal needle biopsy of the prostate. BJU Int 100:51-57, 2007
12)Duplessis CA, Bavaro M, Simons MP, et al:Rectal cultures before transrectal ultrasound-guided prostate biopsy reduce post-prostatic biopsy infection rates. Urology 79:556-561, 2012
13)Goossens H, Ferech M, Vander Stichele R, et al:Outpatient antibiotic use in Europe and association with resistance:a cross-national database study. Lancet 365:579-587, 2005